Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV

See the CDC's interim guidance for pre-exposure prophylaxis of HIV infection

You may have patients asking for Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV.

Prophylaxis after exposure isn't new...it's standard practice for babies born to HIV-positive moms and people exposed to infected fluids.

Now there's evidence that CHRONIC prophylaxis reduces the risk of HIV infection in high-risk men who have sex with men.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote